论文部分内容阅读
[目的]观察改善睡眠质量对功能性消化不良(FD)疗效的影响。[方法]选择符合FD诊断的患者147例,进行匹兹堡睡眠质量指数(PSQI)量表的筛查,选出得分≥8分的患者100例,随机分为2组,对照组50例,给予雷贝拉唑、伊托必利;治疗组50例,在对照组的基础上加用改善睡眠质量的药物黛力新,均观察8周。[结果]治疗8周后,治疗组的症候学改善率(89.8%)明显高于对照组(62.2%),(P<0.01);治疗组的睡眠质量改善率(63.3%)明显高于对照组(26.7%),(P<0.01)。[结论]睡眠障碍在FD患者中普遍存在,约占68%。黛力新既可以改善FD患者睡眠,也可以提高FD疗效,改善情绪障碍。
[Objective] To observe the effect of improving sleep quality on functional dyspepsia (FD). [Methods] A total of 147 patients with FD diagnosis were screened, and the Pittsburgh Sleep Quality Index (PSQI) scale was screened. 100 patients with a score of ≥8 were selected and randomly divided into two groups. The control group received 50 Rabeprazole, itopride; treatment group 50 cases, in the control group based on the use of drugs to improve sleep quality Deanxit, were observed for 8 weeks. [Results] After 8 weeks of treatment, the improvement rate of symptomology in the treatment group (89.8%) was significantly higher than that in the control group (62.2%) (P <0.01); the improvement rate of the sleep quality in the treatment group was significantly higher than that of the control Group (26.7%), (P <0.01). [Conclusion] Sleep disorders are common in FD patients, accounting for about 68%. Deanxit can both improve FD patients sleep, but also can improve the FD effect, improve mood disorders.